are glp 1 considered specialty drugs Insights from Physicians on GLP-1RA Medications Off-Label Use The GLP-1 Access Gap: Mapping
Description
If someone is healthy and not obese, then the benefits are less, but the risks are the same
Are There Differences In Long-Term Outcomes Between These Weight Loss Medications
doi: 10.1111/jdi.12861
Drugs 74 , 20972103 (2014)
27 , 29 , 40 , 43 Similarly, SURMOUNT-1, which evaluated tirzepatide, a dual GLP-1/GIP RA, reported mean reductions of 6.4 mm Hg SBP and 3.6 mm Hg DBP at the highest dose
